Orosil Smiths India Limited (OROSMITHS.BO)
INR 4.22
(2.68%)
INR 4.22
(2.68%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -537 Thousand | 102 Thousand | -11 Thousand | 319.9 Thousand | 666.15 Thousand | 495.35 Thousand |
| Net Income | -4.06 Million | -3.46 Million | -1.93 Million | -4.04 Million | -2.62 Million | -4.91 Million |
| Depreciation & Amortization | 1.46 Million | 1.31 Million | 1.26 Million | 1.24 Million | 1.59 Million | 1.66 Million |
| Deferred income taxes | 11 Thousand | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.25 Million | 2.25 Million | 1.53 Million | 2.29 Million | 1.81 Million | 4.01 Million |
| Other non-cash items | 1.44 Million | -10 Thousand | -877 Thousand | 818.56 Thousand | -126.26 Thousand | -262.61 Thousand |
| Investing Cash Flow | 181 Thousand | -53 Thousand | 604 Thousand | -487.67 Thousand | -48.51 Thousand | 84.27 Thousand |
| Investments in PPE | -54 Thousand | -471 Thousand | -157 Thousand | -55.07 Thousand | -84.71 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -450.83 Thousand | - | - |
| Sales/Maturities of investments | 53 Thousand | 225 Thousand | - | - | - | - |
| Other Investing Activities | 182 Thousand | 193 Thousand | 761 Thousand | 18.23 Thousand | 36.19 Thousand | 84.27 Thousand |
| Financing Cash Flow | - | -293 Thousand | - | - | -425 Thousand | -600.61 Thousand |
| Debt repayment | - | -293 Thousand | - | - | -425 Thousand | -542.58 Thousand |
| Dividends payments | - | -293 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -58.03 Thousand |
| Accounts receivables | - | - | - | 343.37 Thousand | 274.24 Thousand | 1.07 Million |
| Accounts payables | - | - | - | 1.00 | 284.08 Thousand | -67.95 Thousand |
| Inventory | 1.27 Million | 158 Thousand | 317 Thousand | 1.55 Million | 1.77 Million | 834.26 Thousand |
| Other working capital | 972 Thousand | 2.09 Million | 1.21 Million | 403.56 Thousand | -511.34 Thousand | 2.16 Million |
| Cash at beginning of period | 467 Thousand | 1.03 Million | 438 Thousand | 605.63 Thousand | 412.99 Thousand | 433.97 Thousand |
| Cash at end of period | 430 Thousand | 787 Thousand | 1.03 Million | 437.85 Thousand | 605.63 Thousand | 412.99 Thousand |
| Capital Expenditure | -54 Thousand | -471 Thousand | -157 Thousand | -55.07 Thousand | -84.71 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | 1.00 |
| Net cash flow / Change in cash | -37 Thousand | -244 Thousand | 593 Thousand | -167.77 Thousand | 192.63 Thousand | -20.98 Thousand |
| Free Cash Flow | -591 Thousand | -369 Thousand | -168 Thousand | 264.82 Thousand | 581.44 Thousand | 495.35 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.06 Million | -734 Thousand | -1.61 Million | -1.03 Million | -9000.00 | -3.46 Million |
| Depreciation & Amortization | 1.46 Million | 363 Thousand | 365 Thousand | 367 Thousand | 688 Thousand | 1.31 Million |
| Deferred income taxes | 11 Thousand | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.25 Million | - | - | - | - | 2.25 Million |
| Other non-cash items | 1.44 Million | -363 Thousand | -365 Thousand | -367 Thousand | -688 Thousand | -10 Thousand |
| Investing Cash Flow | 181 Thousand | - | - | - | - | -53 Thousand |
| Investments in PPE | -54 Thousand | - | - | - | - | -471 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 53 Thousand | - | - | - | - | 225 Thousand |
| Other Investing Activities | 182 Thousand | - | - | - | - | 193 Thousand |
| Financing Cash Flow | - | - | - | - | - | -293 Thousand |
| Debt repayment | - | - | - | - | - | -293 Thousand |
| Dividends payments | - | - | - | - | - | -293 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 1.27 Million | - | - | - | - | 158 Thousand |
| Other working capital | 972 Thousand | - | - | - | - | 2.09 Million |
| Cash at beginning of period | 467 Thousand | 497 Thousand | 2.11 Million | 467 Thousand | 476 Thousand | 1.03 Million |
| Cash at end of period | 430 Thousand | -734 Thousand | 497 Thousand | -1.03 Million | 467 Thousand | 787 Thousand |
| Capital Expenditure | -54 Thousand | - | - | - | - | -471 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -37 Thousand | -1.23 Million | -1.61 Million | -1.49 Million | -9000.00 | -244 Thousand |
| Free Cash Flow | -591 Thousand | -734 Thousand | -1.61 Million | -1.03 Million | -9000.00 | -369 Thousand |
IONAF
GSK
DHANUKA
KESAR
LRE
VEERKRUPA